Nimble Science

Calgary, Canada Founded: 2018 • Age: 8 yrs
Developer of personalised medicine for gut health
Request Access

About Nimble Science

Nimble Science is a company based in Calgary (Canada) founded in 2018 by Sabina Bruehlmann and Joseph Wang.. Nimble Science has raised $2.7 million across 1 funding round from investors including University of Calgary, Fusion Fund and First Spark Ventures. Nimble Science offers products and services including SIMBA GI Platform, Biopharma Services, and Nutrition Services. Nimble Science operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.

  • Headquarter Calgary, Canada
  • Founders Sabina Bruehlmann, Joseph Wang
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.7 M (USD)

    in 1 rounds

  • Latest Funding Round
    $2.7 M (USD), Seed

    Apr 04, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Nimble Science

Nimble Science offers a comprehensive portfolio of products and services, including SIMBA GI Platform, Biopharma Services, and Nutrition Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Autonomous capsule for collecting multi-omic data from small intestine.

Partnerships for biopharma and nutrition data analysis.

Support for validating microbiome changes in nutrition.

People of Nimble Science
Headcount 1-10
Employee Profiles 4
Employee Profiles
People
Joseph Wang
Chief Technology Officer
People
Sabina Bruehlmann
Chief Executive Officer
People
Cedoljub Bundalovic-Torma
Senior Scientist, Data And Bioinformatics

Unlock access to complete

Funding Insights of Nimble Science

Nimble Science has successfully raised a total of $2.7M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.7 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $2.7M
  • First Round

    (04 Apr 2023)

  • Investors Count 11
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2023 Amount Seed - Nimble Science Valuation Fusion Fund
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Nimble Science

Nimble Science has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Calgary, Fusion Fund and First Spark Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investment in early-stage startups focusing on healthcare, AI, and industrial technology.
Founded Year Domain Location
A venture capital fund focused on deep tech innovations is managed.
Founded Year Domain Location
Venture capital investing and portfolio management services for accredited investors.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Nimble Science

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Nimble Science

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Nimble Science Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Nimble Science

Nimble Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
domain founded_year HQ Location
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
domain founded_year HQ Location
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
domain founded_year HQ Location
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
domain founded_year HQ Location
Therapeutics for aging diseases are developed by targeting senescent cells.
domain founded_year HQ Location
Diagnostic services are provided through laboratories and radiology units.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Nimble Science

Frequently Asked Questions about Nimble Science

When was Nimble Science founded?

Nimble Science was founded in 2018 and raised its 1st funding round 5 years after it was founded.

Where is Nimble Science located?

Nimble Science is headquartered in Calgary, Canada. It is registered at Calgary, Alberta, Canada.

Who is the current CEO of Nimble Science?

Sabina Bruehlmann is the current CEO of Nimble Science. They have also founded this company.

Is Nimble Science a funded company?

Nimble Science is a funded company, having raised a total of $2.7M across 1 funding round to date. The company's 1st funding round was a Seed of $2.7M, raised on Apr 04, 2023.

What does Nimble Science do?

Nimble Science was founded in 2018 in Calgary, Canada. Operations center on biotechnology for gut health, where probiotic-based medicines, novel capsules, and small intestine sampling tools are developed. Gut microorganisms are sequenced and mapped, while biomarkers are collected to enable personalised treatments. Diagnostic innovations are also pursued to support microbiome analysis in the healthcare sector.

Who are the top competitors of Nimble Science?

Nimble Science's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.

What products or services does Nimble Science offer?

Nimble Science offers SIMBA GI Platform, Biopharma Services, and Nutrition Services.

Who are Nimble Science's investors?

Nimble Science has 11 investors. Key investors include University of Calgary, Fusion Fund, First Spark Ventures, Alumni Ventures, and Joyance Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available